BCG vaccine-induced lupus vulgaris [10]

European Journal of Dermatology

Volumn 17, Issue 6, 2007, Pages 547-548

  Attia, Enas ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE DURATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LABORATORY TEST; LANGHANS GIANT CELL; LETTER; LUPUS VULGARIS; MONONUCLEAR CELL; PHYSICAL EXAMINATION; SKIN ATROPHY; SKIN GRANULOMA; SKIN NECROSIS; SKIN NODULE; SKIN REDNESS; SKIN SCAR; SKIN TUBERCULOSIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ANTIBIOTICS, ANTITUBERCULAR; BCG VACCINE; FEMALE; HUMANS; LUPUS VULGARIS; MYCOBACTERIUM BOVIS; SKIN; TUBERCULOSIS;

EID: 36749077557     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Bellet JS, Prose NS. Skin complications of Bacillus Calmette- Guérin immunization. Curr Opin Infect Dis 2005; 18: 97-100.
2. Handjani F, Delir S, Sodaifi M, Kumar PV. Lupus vulgaris following bacilli calmette-Guérin vaccination. Br J Dermatol 2001; 144: 444-5.
3. Tan HH, Seow CS. A review of cutaneous granulomas and lupus vulgaris following BCG vaccination in a skin hospital in Singapore. Ann Acad Med Singapore 2002; 31 (5): 663-5 (abstract).
4. Kanwar AJ, Kaur S, Bansal R, Radotra BD, Sharma R. Lupus vulgaris following BCG vaccination (letter). Int J Dermatol 1988; 27: 525-6.
5. Sierfling U, Penneys NS, Leonardi CL. Identification of Mycobacterium tuberculosis DNA in a case of lupus vulgaris. J Am Acad Dermatol 1993; 28: 318-22.
6. Wozniacka A, Schwartz RA, Sysa-Jedrzejowska A, Borun M, Arkuszewska C. Lupus vulgaris: report of two cases. Int J Dermatol 2004; 44: 299-301.